
Sign up to save your podcasts
Or


Episode #2 of a 2-part series. Part 2 is all about how to handle specific scenarios and clinical pearls. We delve into methotrexate optimization, what to do when therapy fails, the safety of JAK inhibitors, pregnancy management in RA, DMARDs and malignancy, palindromic rheumatism, perioperative management, biosimilars and more.
By Dr. Karim Ladak5
181181 ratings
Episode #2 of a 2-part series. Part 2 is all about how to handle specific scenarios and clinical pearls. We delve into methotrexate optimization, what to do when therapy fails, the safety of JAK inhibitors, pregnancy management in RA, DMARDs and malignancy, palindromic rheumatism, perioperative management, biosimilars and more.

1,869 Listeners

498 Listeners

48 Listeners

131 Listeners

3,362 Listeners

116 Listeners

8,665 Listeners

121 Listeners

191 Listeners

515 Listeners

370 Listeners

67 Listeners

191 Listeners

270 Listeners

19 Listeners